ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.498,38
0,32%
S&P 500
5.187,67
0,00%
Dow Jones
39.056,39
0,44%
Euro vs US Dollar
1,07464
0,00%
Bitcoin
61.507,64
0,52%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Instill Bio Inc (TIL)

  7. Instill Bio Inc (TIL) News

TIL

Instill Bio (TIL)

Instill Bio Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:TIL
DatumZeitQuelleÜberschriftSymbolFirma
21/03/202422h00GlobeNewswire Inc.Instil Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:TILInstill Bio Inc
14/02/202422h08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TILInstill Bio Inc
13/02/202423h36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TILInstill Bio Inc
18/01/202413h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TILInstill Bio Inc
16/01/202423h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TILInstill Bio Inc
16/01/202414h00GlobeNewswire Inc.Instil Bio Announces Strategic UpdateNASDAQ:TILInstill Bio Inc
11/01/202402h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TILInstill Bio Inc
11/01/202401h49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TILInstill Bio Inc
08/12/202323h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TILInstill Bio Inc
05/12/202323h00GlobeNewswire Inc.Instil Bio Announces Effective Date of 1-for-20 Reverse Stock SplitNASDAQ:TILInstill Bio Inc
27/11/202313h13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TILInstill Bio Inc
13/11/202323h27Edgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:TILInstill Bio Inc
13/11/202323h03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TILInstill Bio Inc
13/11/202323h00GlobeNewswire Inc.Instil Bio Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:TILInstill Bio Inc
13/11/202323h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TILInstill Bio Inc
06/11/202313h00GlobeNewswire Inc.Instil Bio Announces Poster Presentations of ITIL-306 Preclinical Data at SITC 2023 Annual MeetingNASDAQ:TILInstill Bio Inc
14/08/202313h05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TILInstill Bio Inc
14/08/202313h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TILInstill Bio Inc
14/08/202313h00GlobeNewswire Inc.Instil Bio Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:TILInstill Bio Inc
26/06/202322h38GlobeNewswire Inc.Instil Bio Announces Oral Presentation of ITIL-306 Preclinical Data at British Society for Gene and Cell Therapy Annual ConferenceNASDAQ:TILInstill Bio Inc
26/06/202322h33Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TILInstill Bio Inc
14/06/202322h32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TILInstill Bio Inc
11/05/202313h06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TILInstill Bio Inc
11/05/202313h00GlobeNewswire Inc.Instil Bio Reports First Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:TILInstill Bio Inc
28/04/202322h37Edgar (US Regulatory)Revised Proxy Soliciting Materials (definitive) (defr14a)NASDAQ:TILInstill Bio Inc
24/04/202322h31Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:TILInstill Bio Inc
10/04/202315h38Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:TILInstill Bio Inc
31/03/202313h40Edgar (US Regulatory)Annual Report (10-k)NASDAQ:TILInstill Bio Inc
31/03/202313h08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TILInstill Bio Inc
31/03/202313h00GlobeNewswire Inc.Instil Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate UpdateNASDAQ:TILInstill Bio Inc
 Showing the most relevant articles for your search:NASDAQ:TIL

Kürzlich von Ihnen besucht

AMEX
XLV
Health Care Select Sector
PM
XAUUSD
Gold vs US Dollar
USOTC
ADDYY
Adidas (QX)
NYSE
NKE
Nike
DBI
DAX
DAX
CCOM
US30
US 30
TG
ALV
Allianz
NASDAQ
AAPL
Apple
AMEX
XLF
Financial Select Sector
USOTC
DTEGY
Deutsche Telekom (QX)
NASDAQ
MSFT
Microsoft
TG
RHM
Rheinmetall
NASDAQ
TSLA
Tesla
DBI
SDXP
SDAX
AMEX
SPY
SPDR S&P 500
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten